Volume 16, Issue 1, January 2026
Main Menu
Solid Lipid Nanoparticles as Next-Generation Carriers for Targeted Prostate Cancer Therapy: A Comprehensive Review (Review Article)
Author(s): *K.L. Deepthi, N. Tirupathi Rao*, B. Haritha, K. Gowthami, M. Shanumukh Kishor, and Ch. Jhansi
Abstract: Solid lipid nanoparticles (SLNs) represent a rapidly advancing nanotechnology platform for the delivery of abiraterone acetate, with promising applications in drug delivery, clinical therapeutics, and biomedical research. This review provides a comprehensive overview of SLNs, including their objectives, production techniques, advantages, limitations, and potential strategies to overcome these challenges. Additionally, the review summarizes commonly employed SLN preparation methods, characterization approaches, and routes of administration. The in vivo behavior of SLN carriers, including their biodistribution and fate within biological systems, is also discussed.
PAGES: 1-7 | 12 VIEWS 12 DOWNLOADS
How To Cite this Article:
*K.L. Deepthi, N. Tirupathi Rao*, B. Haritha, K. Gowthami, M. Shanumukh Kishor, and Ch. Jhansi. Solid Lipid Nanoparticles as Next-Generation Carriers for Targeted Prostate Cancer Therapy: A Comprehensive Review (Review Article). 2026; 16(1): 1-7.
